# | Name | Year | Age | H | Team | DY+/- | POS | GP | SOG | S% | G | A1 | A2 | P | P1 | SOG/G | G/G | A1/G | A2/G | P/G | P1/G | SITP1% | G/P1% |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | John Stevens | 24-25 | 30.44 | L | ABB | +13 | C | 18 | 21 | 14.3% | 3 | 5 | 3 | 11 | 8 | 1.17 | 0.17 | 0.28 | 0.17 | 0.61 | 0.44 | 100.0% | 37.5% |
2 | John Stevens | 23-24 | 29.43 | L | ABB | +12 | C | 68 | 99 | 14.1% | 14 | 11 | 10 | 35 | 25 | 1.46 | 0.21 | 0.16 | 0.15 | 0.51 | 0.37 | 100.0% | 56.0% |
3 | John Stevens | 22-23 | 28.43 | L | ABB | +11 | C | 43 | 72 | 8.3% | 6 | 9 | 4 | 19 | 15 | 1.67 | 0.14 | 0.21 | 0.09 | 0.44 | 0.35 | 100.0% | 40.0% |
4 | John Stevens | 21-22 | 27.43 | L | ABB | +10 | C | 68 | 100 | 19.0% | 19 | 14 | 10 | 43 | 33 | 1.47 | 0.28 | 0.21 | 0.15 | 0.63 | 0.49 | 100.0% | 57.6% |
5 | John Stevens | 20-21 | 26.43 | L | UTI | +9 | C | 24 | 38 | 15.8% | 6 | 3 | 1 | 10 | 9 | 1.58 | 0.25 | 0.13 | 0.04 | 0.42 | 0.38 | 100.0% | 66.7% |
6 | John Stevens | 19-20 | 25.43 | L | BRI | +8 | C | 16 | 17 | 17.6% | 3 | 2 | 0 | 5 | 5 | 1.06 | 0.19 | 0.13 | 0.0 | 0.31 | 0.31 | 100.0% | 60.0% |
7 | John Stevens | 19-20 | 25.43 | L | UTI | +8 | C | 24 | 28 | 10.7% | 3 | 5 | 1 | 9 | 8 | 1.17 | 0.13 | 0.21 | 0.04 | 0.38 | 0.33 | 100.0% | 37.5% |
8 | John Stevens | 18-19 | 24.43 | L | BRI | +7 | C | 25 | 26 | 11.5% | 3 | 1 | 3 | 7 | 4 | 1.04 | 0.12 | 0.04 | 0.12 | 0.28 | 0.16 | 100.0% | 75.0% |
9 | *John Stevens | 17-18 | 23.43 | L | BRI | +6 | C | 68 | 84 | 8.3% | 7 | 7 | 5 | 19 | 14 | 1.24 | 0.1 | 0.1 | 0.07 | 0.28 | 0.21 | 100.0% | 50.0% |
10 | *John Stevens | 16-17 | 22.43 | L | BRI | +5 | C | 8 | 6 | 0.0% | 0 | 1 | 0 | 1 | 1 | 0.75 | 0.0 | 0.13 | 0.0 | 0.13 | 0.13 | 100.0% | 0.0% |